| Literature DB >> 24381569 |
Abstract
Synechococcus sp. WH 8102 is a motile marine cyanobacterium isolated originally from the Sargasso Sea. To test the response of this organism to cadmium (Cd), generally considered a toxin, cultures were grown in a matrix of high and low zinc (Zn) and phosphate (PO4 (3-)) and were then exposed to an addition of 4.4 pM free Cd(2+) at mid-log phase and harvested after 24 h. Whereas Zn and PO4 (3-) had little effect on overall growth rates, in the final 24 h of the experiment three growth effects were noticed: (i) low PO4 (3-) treatments showed increased growth rates relative to high PO4 (3-) treatments, (ii) the Zn/high PO4 (3-) treatment appeared to enter stationary phase, and (iii) Cd increased growth rates further in both the low PO4 (3-) and Zn treatments. Global proteomic analysis revealed that: (i) Zn appeared to be critical to the PO4 (3-) response in this organism, (ii) bacterial metallothionein (SmtA) appears correlated with PO4 (3-) stress-associated proteins, (iii) Cd has the greatest influence on the proteome at low PO4 (3-) and Zn, (iv) Zn buffered the effects of Cd, and (v) in the presence of both replete PO4 (3-) and added Cd the proteome showed little response to the presence of Zn. Similar trends in alkaline phosphate (ALP) and SmtA suggest the possibility of a Zn supply system to provide Zn to ALP that involves SmtA. In addition, proteome results were consistent with a previous transcriptome study of PO4 (3-) stress (with replete Zn) in this organism, including the greater relative abundance of ALP (PhoA), ABC phosphate binding protein (PstS) and other proteins. Yet with no Zn in this proteome experiment the PO4 (3-) response was quite different including the greater relative abundance of five hypothetical proteins with no increase in PhoA or PstS, suggesting that Zn nutritional levels are connected to the PO4 (3-) response in this cyanobacterium. Alternate ALP PhoX (Ca) was found to be a low abundance protein, suggesting that PhoA (Zn, Mg) may be more environmentally relevant than PhoX.Entities:
Keywords: Synechococcus; alkaline phosphatase; cadmium; cyanobacteria; metallothionein; phosphate stress; proteome; zinc
Year: 2013 PMID: 24381569 PMCID: PMC3865332 DOI: 10.3389/fmicb.2013.00387
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Phycoerythrin fluorescence vs. time, chronic PO. Error bars are one standard deviation of triplicate 28 mL tubes. Note that no PO43− added treatments, both with and without Zn appear to have a stationary phase. 1 μM PO43− treatments appear to have a brief stationary phase and then enter death phase, the Zn dying faster than the no Zn. The 5 μM PO43− treatments fluoresced to a greater maximum than the 65 μM PO43−.
Figure 2Experimental Design. Four experimental treatments with variable Zn and PO43− concentrations were grown to mid-log phase, split evenly and 4.4 pM Cd2+ added acutely to one of the splits of each treatment.
Figure 3Cell numbers vs. time, growth rates, and final cell numbers. (A) no Zn/low PO43− with and without short-term Cd addition, (B) Zn/low PO43− with and without short-term Cd addition, (C) no Zn/high PO43− with and without short-term Cd addition, (D) Zn/high PO43− with and without short-term Cd addition, (E) growth rates, (F) growth rates in the 24 h after Cd addition until harvest and (G) final cell numbers at harvest. Vertical lines mark time of Cd addition. Note that final cell numbers are higher in low than high phosphate. n, number of timepoints.
Figure 4Cluster analysis of relative protein abundances. no Zn/65 μM PO43−, Zn/65 μM PO43−, no Zn/1 μM PO43−, Zn/1 μM PO43− and these four chronic treatments with short term 4.4 pM Cd2+ added. The four low PO43− treatments are on the right and replete, and high PO43− on the left. There are 71 proteins. Protein relative abundances are averages of duplicates, have at least 7 counts, and are different by a value of 7. Data are log transformed, centered, and clustered by Kendall's Tau, centroid linkage. Yellow, more abundant; Blue, less abundant; *, statistically different by Fisher's Exact Test between the no Zn/high PO43− and the no Zn/high PO43−/short-term Cd; **, differentially abundant by two-fold or greater and statistically different by Fisher's Exact Test between the no Zn/high PO43− and the no Zn/high PO43−/short-term Cd.
Figure 5Number of proteins two-fold or more abundant in pairwise comparisons, with other matix treatments equivalent (color bar on x-axis corresponds with Figure Proteins more abundant with scarce PO43− relative to replete conditions and vice versa (right and left bars, respectively). (B) Proteins more abundant with short-term Cd addition relative to no Cd added and vice versa (right and left bars, respectively). (C) Proteins more abundant with scarce Zn relative to replete conditions and vice versa (left and right bars, respectively). Comparison of (A–C) shows that the combination of Zn and PO43− scarcity causes the greatest number of proteins to be differentially abundant. (B) shows that the presence of Zn causes less change in number of proteins when Cd is added. Functions and abundances for each protein are in Tables 1–3 and Supplementary Tables 1A,B, and D–J.
Relative protein abundances between low and high phosphate treatments for proteins two-fold or greater differentially abundant (1 μM PO.
| 2391 | u,p | Putative alkaline phosphatase | 8.1 ± 0.8 | 1.0 ± 0.0 | +8.1 |
| 1018 | abc,p | ABC transporter, substrate binding protein, phosphate (PstS) | 76.9 ± 1.3 | 19.2 ± 2.4 | +4.0 |
| 1661 | ukn | Hypothetical protein | 5.2 ± 2.1 | 1.4 ± 0.7 | +3.7 |
| 0953 | mo | Cell surface protein required for swimming motility (SwmB) | 5.2 ± 0.6 | 1.4 ± 0.7 | +3.7 |
| 0359 | u,zn | Bacterial metallothionein (SmtA) | 7.1 ± 3.2 | 3.3 ± 0.6 | +2.2 |
| 0085 | mo | Cell surface protein required for swimming motility (SwmA) | 9.0 ± 0.8 | 4.2 ± 0.6 | +2.1 |
| 0799 | m,e,c | Glyceraldehyde−3−phosphate dehydrogenase (Gap3) | 2.4 ± 0.6 | 0.5 ± 0.7 | +4.7 |
| 2224 | u,om | Possible porin (Som) | 61.2 ± 1.7 | 29.4 ± 2.6 | +2.1 |
| 1773 | m,nu,pu,a | Adenylosuccinate synthetase (PurA, AdeK) | 1.4 ± 0.7 | 7.5 ± 0.1 | −5.2 |
| 0814 | m,nu, pu | Adenine phosphoribosyltransferase | 1.0 ± 0.0 | 5.1 ± 0.8 | −5.1 |
| 2500 | m,cb,tca, e,c | Aconitate hydratase (AcnB) | 2.8 ± 0.0 | 7.5 ± 0.1 | −2.6 |
| 2069 | gi,t | 50S ribosomal protein L23 (Rpl23,RplW) | 3.8 ± 1.3 | 8.9 ± 0.5 | −2.3 |
| 2068 | gi,t | 50S ribosomal protein L4 (Rpl4,RplD) | 4.3 ± 2.1 | 9.3 ± 0.2 | −2.2 |
| 2079 | gi,t | 50S ribosomal protein L5 (Rpl5,RplE) | 5.2 ± 1.9 | 10.7 ± 0.4 | −2.1 |
| 1716 | c | Putative carboxysome structural peptide (CsoS2) | 6.6 ± 0.1 | 13.1 ± 1.6 | −2.0 |
| 2136 | gi,t | 30S ribosomal protein S7 (Rps7,RpsG) | 8.1 ± 0.5 | 15.9 ± 1.0 | −2.0 |
| 2083 | gi,t | 30S ribosomal protein S5 (Rps5,RpsE) | 5.2 ± 0.8 | 10.3 ± 0.2 | −2.0 |
| 2082 | gi,t | 50S ribosomal protein L18 (Rpl18,RplR) | 3.3 ± 0.6 | 6.5 ± 2.5 | −2.0 |
Units are spectral counts.
Corresponding transcript identified in Tetu et al. (2009) as strongly upregulated under early P-stress [5 μM PO43−];
Corresponding transcript identified in Tetu et al. (.
Relative protein abundances between added (+ 4.4 pM Cd.
| 0908 | ukn | Hypothetical protein | 6.2 ± 0.5 | 1.3 ± 0.6 | +4.9 | 95% (0.01) |
| 0670 | ukn | Hypothetical protein | 7.2 ± 0.4 | 2.2 ± 1.9 | +3.3 | 95% (0.0048) |
| 0827 | ukn | Hypothetical protein | 11.0 ± 2.4 | 3.4 ± 0.1 | +3.2 | 95% (0.0016) |
| 2191 | ps | Photosystem II complex extrinsic protein precursor (PsuB) | 13.8 ± 0.2 | 5.5 ± 1.7 | +2.5 | 95% (0.0016) |
| 0082 | m,v,r | Riboflavin synthase subunit beta (RibH) | 8.6 ± 2.4 | 4.3 ± 0.1 | +2.0 | 95% (0.047) |
| 1118 | m,cb | Glucose−1−phosphate adenylyltransferase (Agp, GlgC) | 1.5 ± 0.7 | 5.5 ± 0.5 | −3.6 | 95% (0.019) |
| 0405 | m,nu,pu,a | fumarate lyase: adenylosuccinate lyase (PurB) | 1.9+0.1 | 6.4 ± 0.8 | −3.4 | 95% (0.041) |
| 2139 | gi,t | 30S ribosomal protein S10 (Rps10, RpsJ) | 1.9 ± 0.1 | 5.5 ± 1.7 | −2.9 | 0% (0.09) |
| 1953 | ukn,l | Putative glycerol kinase | 2.4 ± 2.1 | 5.6 ± 2.0 | −2.3 | 0% (0.15) |
| 2500 | m,cb,tca,e,c | Aconitate hydratase (AcnB) | 2.4 ± 0.7 | 5.1 ± 1.3 | −2.1 | 0% (0.21) |
Units are spectral counts.
Arranged in highest to lowest fold change 4.4 pM Cd.
Figure 6Fold change in protein relative abundance (this experiment) as ratio of low phosphate to high phosphate vs. log. Pink dots represent proteins/transcripts more than two-fold abundant in both protein and transcript data. Black dots represent proteins/transcripts more than two-fold abundant in transcript data. Red dashed line indicates a 1:1 equal fold abundance. SYNW0160 conserved hypothetical protein; SYNW1119 6-phosphogluconate dehydrogenase; SYNW1213 thioredoxin peroxidase; SYNW1815 ABC transporter, substrate binding protein, phosphate; SYNW0406 hypothetical protein; SYNW2508 molecular chaperone DnaK2, heat shock protein hsp 70-2. See Tables 1, 2.
Figure 7Relative protein abundances of SYNW0359 bacterial metallothionein, SYNW2391 putative alkaline phosphatase, and SYNW1018 ABC transporter, substrate binding protein, phosphate (PstS). Hatched bars were subjected to short-term Cd additions. Error bars are the standard deviation of duplicate injections. Note greater relative abundances of the alkaline phosphatase and PstS in the 1 μM PO43− compared to the 65 μM PO43− treatments. Note the greater relative abundances of the alkaline phosphatase in the 1 μM PO43− treatments with Zn compared to no Zn.
Relative protein abundances between low and high phosphate treatments for proteins two-fold or greater differentially abundant (1 μM PO.
| 0380 | ukn | Hypothetical protein | 13.5 ± 4.7 | 0.4 ± 0.6 | +31.0 |
| 0727 | gi,re | DNA gyrase subunit A (GyrA) | 5.9 ± 2.2 | 0.9 ± 0.0 | +6.9 |
| 0235 | m,cb,as | Phosphoglucomutase/phosphomannomutase family protein | 5.7 ± 0.1 | 0.9 ± 0.1 | +6.2 |
| 1610 | rg | Putative bifuntional enzyme: tRNA methyltransferase; 2−C−methyl−D−erythritol 2,4−cyclodiphosphate synthase | 5.0 ± 0.9 | 0.9 ± 0.1 | +5.3 |
| 1090 | gi,t | 30S ribosomal protein S2 (Rps2,RpsB) | 7.4 ± 0.2 | 1.7 ± 0.0 | +4.3 |
| 1145 | ukn | Hypothetical protein | 5.2 ± 3.2 | 1.3 ± 0.6 | +4.0 |
| 0670 | ukn | Hypothetical protein | 8.6 ± 4.2 | 2.2 ± 1.9 | +4.0 |
| 0278 | m,nu,py | Deoxycytidine triphosphate deaminase (Dcd) | 8.1 ± 0.9 | 2.1 ± 0.7 | +3.8 |
| 0827 | ukn | Hypothetical protein | 12.9 ± 2.3 | 3.4 ± 0.1 | +3.8 |
| 0340 | ukn | Hypothetical protein | 7.4 ± 0.2 | 2.1 ± 0.7 | +3.5 |
| 1171 | m,a,gi,t | aminotransferase class−I (AspC) | 7.6 ± 2.5 | 2.6 ± 0.1 | +3.0 |
| 0402 | m,l | Possible acyl carrier protein | 5.0 ± 0.9 | 2.1 ± 0.5 | +2.3 |
| 1852 | m,l | 3−oxoacyl−[acyl carrier protein] reductase (FabG) | 5.9 ± 2.2 | 2.6 ± 0.1 | +2.3 |
| 0144 | ps | Photosystem I subunit VII (PsaC) | 10.2 ± 4.1 | 4.7 ± 1.9 | +2.2 |
| 0535 | ps | Ferredoxin (PetF4) | 12.7 ± 4.7 | 6.0 ± 0.1 | +2.1 |
| 1936 | abc,s | Putative sulfate transporter | 5.2 ± 3.2 | 2.6 ± 2.5 | +2.0 |
| 1091 | gi | Elongation factor Ts (Tsf) | 0.9 ± 1.3 | 10.2 ± 1.5 | −11.0 |
| 1816 | ukn | Hypothetical protein | 0.7+1.0 | 6.8 ± 1.0 | −9.4 |
| 0303 | ps | Photosystem II manganese−stabilizing polypeptide (PsbO) | 7.4 ± 0.2 | 35.7 ± 7.5 | −4.8 |
| 1495 | m,v,po,chl | Uroporphyrinogen decarboxylase (HemE) | 1.7 ± 0.3 | 7.7 ± 2.6 | −4.6 |
| 2139 | gi,t | 30S ribosomal protein S10 (Rps10, RpsJ) | 1.2 ± 0.3 | 5.5 ± 1.7 | −4.5 |
| 2081 | gi,t | 50S ribosomal protein L6 (Rpl6,RplF) | 2.4 ± 0.7 | 10.2 ± 2.1 | −4.3 |
| 0852 | ukn | Hypothetical protein | 1.7 ± 0.3 | 5.5 ± 0.5 | −3.3 |
| 2069 | gi,t | 50S ribosomal protein L23 (Rpl23,RplW) | 2.6 ± 1.6 | 8.5 ± 1.0 | −3.3 |
| 2500 | m,cb,tca, e,c | Aconitate hydratase (AcnB) | 1.7 ± 0.3 | 5.1 ± 1.3 | −3.1 |
| 2356 | gi,t | Aspartyl/glutamyl−tRNA amidotransferase subunit B (GatB) | 2.4 ± 0.7 | 7.3 ± 2.0 | −3.0 |
| 1933 | m,v,po,chl | δ-aminolevulinic acid dehydratase (HemB) | 2.4 ± 0.7 | 7.2 ± 1.6 | −3.0 |
| 1025 | m,a | Putative anthranilate synthase component II (TrpD/G) | 3.1 ± 1.8 | 9.0 ± 0.8 | −2.9 |
| 2074 | gi,t | 50S ribosomal protein L16 (Rpl16,RplP) | 2.4 ± 0.7 | 6.8 ± 2.2 | −2.8 |
| 0045 | u,m | Soluble hydrogenase small subunit (DHSS) | 2.6 ± 1.6 | 7.2 ± 2.8 | −2.8 |
| 1982 | ps | Photosystem II chlorophyll−binding protein CP47 (PsbB) | 4.8 ± 1.5 | 13.2 ± 2. | −2.8 |
| 0032 | gi | Putative cyclophilin−type peptidyl−prolyl cis−trans isomerase | 2.2 ± 3.1 | 6.0 ± 0.1 | −2.7 |
| 0033 | gi,t | Elongation factor P (Efp) | 2.4 ± 0.7 | 6.4 ± 2.8 | −2.7 |
| 0750 | m,cb,g | Glucose−6−phosphate dehydrogenase (Zwf) | 4.0 ± 0.4 | 10.7 ± 2.1 | −2.6 |
| 0462 | ei,si | Nitrogen regulatory protein P−II (GlnB) | 2.6 ± 1.6 | 6.8 ± 1.0 | −2.6 |
| 0819 | m,a | Dihydrodipicolinate reductase (DapB) | 2.7 ± 2.4 | 6.8 ± 1.0 | −2.5 |
| 2067 | gi,t | 50S ribosomal protein L3 (Rpl3,RplC) | 4.9 ± 5.5 | 12.0 ± 3.9 | −2.5 |
| 2082 | gi,t | 50S ribosomal protein L18 (Rpl18,RplR) | 3.1 ± 1.8 | 7.7 ± 0.2 | −2.5 |
| 2442 | abc,si | putative urea ABC transporter, urea binding protein (UrtA1) | 24.1 ± 5.0 | 55.9 ± 4.5 | −2.3 |
| 1815 | abc,p | ABC transporter, substrate binding protein, phosphate (PstS) | 4.0 ± 0.4 | 9.4 ± 1.0 | −2.3 |
| 1694 | gi,t | 30S ribosomal protein S4 (Rps4,RpsD) | 4.1 ± 4.4 | 9.4 ± 0.2 | −2.3 |
| 2348 | m,cb,e,gi | Enolase (Eno) | 7.0 ± 4.5 | 5.7 ± 2.6 | −2.3 |
| 1824 | gi,t | 50S ribosomal protein L19 (Rpl19) | 6.6 ± 1.2 | 14.5 ± 0.4 | −2.2 |
| 0687 | m,nu,py | Putative thioredoxin reductase | 2.4 ± 0.7 | 5.1 ± 1.3 | −2.1 |
| 2246 | ei | Two−component response regulator (RpaB) | 5.7 ± 0.1 | 11.9 ± 2.1 | −2.1 |
| 2137 | gi,t | Elongation factor EF−2 (FusA) | 12.1 ± 1.3 | 25.1 ± 1.2 | −2.1 |
| 1835 | ps | Photosystem I reaction center subunit III (PsaF) | 3.3 ± 0.6 | 6.9 ± 2.6 | −2.1 |
| 1718 | c | Ribulose bisphosphate carboxylase, large chain (RbcL,CbbL) | 38.2 ± 11.7 | 78.7 ± 9.4 | −2.1 |
| 0405 | m,nu,pu,a | Fumarate lyase: adenylosuccinate lyase (PurB) | 3.1 ± 1.8 | 6.4 ± 0.8 | −2.1 |
| 1617 | gi,t | 30S ribosomal protein S16 (Rps16,RpsP) | 4.8 ± 1.5 | 9.8 ± 2.1 | −2.1 |
| 2487 | abc,ei | Putative cyanate ABC transporter | 5.5 ± 2.5 | 11.1 ± 2.7 | −2.0 |
| 0514 | gi,f | Chaperonin (GroEL) | 55.8 ± 15.5 | 112.0 ± 0.1 | −2.0 |
| 0613 | u,gi,t | DNA−directed RNA polymerase beta subunit (RpoB) | 4.0 ± 0.4 | 8.1 ± 1.6 | −2.0 |
| 2068 | gi,t | 50S ribosomal protein L4 (Rpl4,RplD) | 5.6 ± 6.5 | 11.1 ± 1.5 | −2.0 |
| 1073 | m,e,n,a | Glutamine synthetase, glutamate−ammonia ligase (GlnA) | 20.0 ± 4.5 | 39.6 ± 1.6 | −2.0 |
Units are spectral counts.
Arranged in highest to lowest fold change Zn-high PO.
Figure 8Proteins more abundant with short-term cadmium addition. Relative protein abundances of proteins two-fold or more greater in abundance and/or statistically different by Fisher's Exact Test in the no Zn/65 μM PO43−/+ 4.4 pM Cd2+ (hatched bars) compared to the no Zn/65 μM PO43− treatments (solid bars). (A) SYNW2009 C-phycoerythrin class II, α chain, (B) SYNW2008 C-phycoerythrin class II, β chain, (C) SYNW2017 C-phycoerythrin class I, β chain, (D) SYNW2369 rubrerythrin, (E) SYNW2124 PSI P700 (PsaA), (F) SYNW3191 PSII extrinsic precursor (PsuB), (G) SYNW0486 anchor polypeptide LCM (ApcE), (H) SYNW1264 peptidyl-prolyl cis-trans isomerase, (I) SYNW0082 riboflavin synthase subunit b (RibH), (J) SYNW2224 possible porin (Som, 2224), (K) SYNW2227 possible porin (Som, 2227), (L) SYNW0827 hypothetical protein (Hypo, 0827), (M) SYNW0406 hypothetical protein (Hypo, 0406), (N) SYNW0908 hypothetical protein (Hypo, 0908), and (O) SYNW0670 hypothetical protein (Hypo, 0670). Error bars are the standard deviation of duplicate injections.
Figure 9Proteins more abundant without short-term cadmium addition. Relative protein abundances of proteins more than two-fold less abundant and/or statistically different by Fisher's Exact Test in the no Zn/65 μM PO43−/+ 4.4 pM Cd2+ (hatched bars) compared to the no Zn/65 μM PO43− treatments (solid bars). (A) SYNW2022 R-phycocyanin II, β chain (RpcB), (B) SYNW0514 chaperonin GroEL (GroEL), (C) SYNW0303 PSII Mn-stabilizing polypeptide (PsbO), (D) SYNW0405 fumarate lyase: adenylosuccinate lyase (PurB), and (E) SYNW2500 aconitate hydratase (AcnB). Error bars are the standard deviation of duplicate injections.